Gereon Lauer
Scientific Director Diagnostics at Novo Nordisk | Copenhagen, Capital Region of Denmark, Denmark
Gereon Lauer’s Email & Phone Number
VerifiedFree account · No credit card · 5 profiles/month
Scientific Director Diagnostics at Novo Nordisk in January 2024 - Present
Vice President Translational Biomarker at Evotec in April 2023 - September 2023
Manager Diagnostics at Miltenyi Biotec in May 2020 - April 2023
Vice President Development, Production and QC at AYOXXA Biosystems GmbH in April 2019 - May 2020
Group Leader Assay Development at AYOXXA Biosystems GmbH in January 2018 - March 2019
Associate Director Discovery Biomarkers at Vertex Pharmaceuticals in January 2013 - December 2017
Senior Group Leader Biomarker Development at Takeda Pharmaceuticals (formerly Nycomed) in July 2010 - January 2013
Biomarker Expert/Laboratory Team Leader (Biomarker Development) at Altana Pharna AG / Nycomed in June 2006 - June 2010
Laboratory Team Leader (Functional Genomics) at Altana Pharma in May 2006 - June 2007
Laboratory Team Leader (Biochemistry/Inflammation) at Altana Pharma in July 2000 - May 2006
University of Cologne, Dr. rer. nat., July 1997 to July 2026
University of Basel, Certificate in Pharmaceutical Medicine Pharmaceutical drug development from discovery to life cycle, July 2026
University of Düsseldorf, Diplom, July 1990 to July 1996
We’re not your typical healthcare company. In a modern world of quick fixes, we focus on solutions to defeat serious chronic disease and create long-term health. Our unordinary mindset is at the heart of everything we do. We seek out new ideas and put people first as we push the boundaries of science, make healthcare more accessible, and work to treat, prevent, and even cure diseases that affect millions of lives. Founded in Denmark in 1923, today we employ more than 68,800 people in 80 offices around the world – all united by our bold purpose to drive change to defeat serious chronic diseases. Want to learn more? Visit www.novonordisk.com. This page isn’t intended for discussions about products. As such, postings or comments that contain product discussions may be removed. This page is for discussions about Novo Nordisk and its subsidiaries and the initiatives and projects we are involved in. While we welcome everyone to make comments, we reserve the right to block and remove those that are off-topic, abusive or intended to spam. Any questions specific to products should be made to your healthcare professional. If you wish to file an adverse drug reaction please contact Novo Nordisk’s office in the country you live in: https://www.novonordisk.com/contact-us/find-local-information.html For other customer complaints, please contact us here: https://www.novonordisk.com/contact-us.html Please keep in mind that Novo Nordisk A/S and its subsidiaries work within a highly regulated industry. Therefore, comments that pertain to legal matters or regulatory issues may be removed. Comments contained on this site come from members of the public, and do not necessarily reflect the views of Novo Nordisk A/S. Novo Nordisk A/S does not endorse or approve any content added by other LinkedIn users. Learn more about our privacy disclaimer and community guidelines here: https://www.novonordisk.com/data-privacy-and-user-rights/social-media-privacy-disclaimer.html
Discover more about Novo Nordisk
Global Director Frontline Excellence Rare Diseases, Novo Nordisk
Owner at Veum Consulting
(March 2015 – Present)
PMP® | Regulatory Affairs Project Lead (Business Area Middle East, Affrica & CIS) at Novo Nordisk
Regulatory Affairs Project Lead (Business Area Middle East, Africa &CIS) at Novo Nordisk
(January 2024 – Present)
Medical Science Liaison, Diabetes & Renal
Wine Rep at ONEHOPE Wine
(June 2021 – Present)
Public Affairs Manager presso Novo Nordisk
Public Affairs Manager at Novo Nordisk
(May 2022 – Present)
Obesity Market Access | Novo Nordisk Canada
Consultant at Global Market Access Solutions
(May 2026 – May 2026)
Associate Director – Novo Nordisk
Student in Business Partner Operation Nordic (BPO) at IBM
(January 2006 – May 2026)
What is Gereon Lauer email address?
Email Gereon Lauer at [email protected] and [email protected]. This email is the most updated Gereon Lauer's email found in 2026.
How to contact Gereon Lauer?
To contact Gereon Lauer send an email to [email protected] or [email protected]. (updated on November 28, 2025)
What company does Gereon Lauer work for?
Gereon Lauer works for Novo Nordisk.
What is Gereon Lauer's role at Novo Nordisk?
Gereon Lauer is Scientific Director Diagnostics
What industry does Gereon Lauer work in?
Gereon Lauer works in the Biotechnology industry.
